Ms. Lu has experience working on multiple phases of patent litigation including pre-suit patent analysis, fact and expert discovery, motion practice, summary judgment, bench and jury trials, and post-trial briefing.
Representative matters include:
- Genzyme Corp. v. Dr. Reddy’s Labs., Ltd., No. 13-1506-GMS (D. Del.) – Represented Teva Pharmaceuticals USA, Inc. in patent infringement litigation, including trial, regarding Teva’s application to market a generic version of Genzyme’s stem cell mobilizing agent, Mozobil® (plerixafor).
- Reckitt Benckiser Pharmaceuticals Inc. v. Dr. Reddy’s Laboratories, S.A., No. 14-1451-RGA (D. Del.) – Represented Dr. Reddy’s in patent infringement litigation, including trial, concerning Dr. Reddy’s application to market a generic version of Suboxone® (buprenorphine hydrochloride and naloxone hydrochloride) sublingual films.
- GlaxoSmithKline v. Teva Pharmaceuticals USA, Inc., No. 14-878-LPS (D. Del.) – Represented Teva in patent litigation, including jury trial, concerning Teva’s generic version of Coreg® (carvedilol) tablets.
- Sophos, Inc. v. RPost Holdings, Inc., No. 13-12856-DJC (D. Mass.) – Represented Sophos in declaratory judgment action regarding Sophos’s network security and email security products.
Ms. Lu also commits to pro bono matters including representing unaccompanied minors through the firm’s partnership with Kids in Need of Defense (KIND).
While in law school, Ms. Lu was a student and student director in the Immigration Legal Services Clinic at Yale Law School, and an editor for the Yale Law Journal. She also worked as a summer intern at the Department of Justice Civil Rights Division, Housing and Civil Enforcement Section.